Frederic Jackson

DPhil Clinical Medicine
2021

Project Title: Improving adenovirus vaccine production

Following graduating from the University of Kent, I worked as an assay scientist at the Clinical BioManufaturing Facility (CBF), University of Oxford. Implementing Next Generation Sequencing (NGS) into a Good Manufacturing Practice (GMP) environment to assess the genetic stability of adenoviral vectors.

As part of my DPhil I am investigating how adenoviral vaccine production can be improved through cell line development to reduce the risk of replication competent adenovirus (RCA) and to improve yield.

Contact: frederic.jackson@ndm.ox.ac.uk